|
Lymphoma Study at Ohio State UniversityDonationAccording to the 2004 Kerry Health Survey 2.7% of all Kerries are affected by this cancer. The average onset was 7 years, with the earliest at age 3. Lymphoma accounts for one quarter of all cancers in Kerries. On May 22, 2008, the Kerry Blue Terreir Foundation donated $820 towards the $15,505 needed for a promising study. William Kissebeth, DVM, PhD, Ohio State, is using the newly canine genome sequence and applying new identification techniques to develop early detection methods for the disease. The Foundation Board made the funds available at their Board meeting of May 14, 2008, based on a recommendation of Board member Dr. W. Jean Dodds. AbstractLymphoma is one of the most common cancers in the dog. Current methods of classifying lymphoma neither explain nor predict its variable clinical behavior. Much of the progress in diagnosis, prognosis, and treatment of lymphoma and other cancers in people has been the result of advances in "genomics." Recently the canine genome has been sequenced, providing the opportunity to apply new genomic approaches to better understand and treat cancer in the dog. MicroRNAs (miRNA) are small non-protein coding molecules that have been implicated in humans as having an important role in cancer and a variety of other diseases. In this study, we will identify miRNAs using bioinformatic methods. We will then use miRNA microarrays to analyze normal canine tissues and canine lymphoma biopsies. These results (miRNA expression profiles) will be correlated with histologic diagnosis and clinical parameters. The goals of this study are to identify canine miRNAs and their normal patterns of expression and to determine if specific histologic subtypes of lymphoma are characterized by unique miRNA expression profiles, if specific miRNAs have prognostic significance, and to identify potential targets for future investigation and therapies. This study will also generate new tools for future miRNA investigation in the dog. Living with Lymphoma in KerriesLexieby Anne Corke Lexie was only six when she was diagnosed with lymphoma in August 2007. We were devastated but determined to do our very best for her. For nine precious months, our lives revolved around her. As her treatment progressed, Lexie rebounded, playing with her toys, chasing squirrels, going for drives and mooching treats from all. We celebrated Christmas, thankful that she was still with us. We celebrated her seventh birthday in January with special birthday dog cookies and a particularly rousing rendition of “Happy Birthday”. But the celebrations were bittersweet since we knew they were the last, that she was living on borrowed time. In the spring, she started to lose ground. On April Fool's Day, she told us she had had enough and we tearfully bid her farewell. To lose our dear Kerries is always heart-wrenching, but to lose a young dog, to see that dog age before your eyes, to be robbed of half their lifespan, well, it just seems so wrong, so unfair. Lexie, in her prime, was beautiful and sassy, busy and bouncy, full of the joy of life. And now she is gone and all we have are photographs and our cherished memories. We are so grateful to the Foundation for supporting research into lymphoma and we pray that one day, there will be a breakthrough, for our dogs sakes and for ours.
Rest in peace, dear Lexie.
|
|